Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs).

Saved in:
Bibliographic Details
Title: Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs).
Authors: Wang, Xin1, Chen, Zhuo1,2 chenzhuo@ecust.edu.cn, Tong, Linjiang2, Tan, Shaoying1, Zhou, Wei1, Peng, Ting2, Han, Kun2, Ding, Jian2, Xie, Hua2 hxie@simm.ac.cn, Xu, Yufang1 yfxu@ecust.edu.cn
Source: European Journal of Medicinal Chemistry. Jul2013, Vol. 65, p477-486. 10p.
Database: Academic Search Ultimate
Description
ISSN:02235234
DOI:10.1016/j.ejmech.2013.05.002